135 related articles for article (PubMed ID: 34400078)
1. Managing the Risk of Delayed Breast Cancer Screening Versus COVID-19 Vaccination Associated Axillary Lymphadenopathy.
Garver K
Acad Radiol; 2021 Sep; 28(9):1198-1199. PubMed ID: 34400078
[No Abstract] [Full Text] [Related]
2. COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram.
Raj S; Ogola G; Han J
Acad Radiol; 2022 Apr; 29(4):501-507. PubMed ID: 34906409
[TBL] [Abstract][Full Text] [Related]
3. Management of Unilateral Axillary Lymphadenopathy Detected on Breast MRI in the Era of COVID-19 Vaccination.
Edmonds CE; Zuckerman SP; Conant EF
AJR Am J Roentgenol; 2021 Oct; 217(4):831-834. PubMed ID: 33543649
[TBL] [Abstract][Full Text] [Related]
4. Management Strategies for Patients Presenting With Symptomatic Lymphadenopathy and Breast Edema After Recent COVID-19 Vaccination.
Hao M; Edmonds CE; Nachiappan AC; Conant EF; Zuckerman SP
AJR Am J Roentgenol; 2022 Jun; 218(6):970-976. PubMed ID: 34964358
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccine-related unilateral axillary lymphadenopathy: Pattern on screening breast MRI allowing for a benign assessment.
Plaza MJ; Wright J; Fernandez S
Clin Imaging; 2021 Dec; 80():139-141. PubMed ID: 34325221
[No Abstract] [Full Text] [Related]
6. Unilateral axillary adenopathy following COVID-19 vaccination: a multimodality pictorial illustration and review of current guidelines.
Brown A; Shah S; Dluzewski S; Musaddaq B; Wagner T; Szyszko T; Wan S; Groves A; Mokbel K; Malhotra A
Clin Radiol; 2021 Aug; 76(8):553-558. PubMed ID: 34053731
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT.
Lane DL; Neelapu SS; Xu G; Weaver O
Korean J Radiol; 2021 Dec; 22(12):1938-1945. PubMed ID: 34719892
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination.
Robinson KA; Maimone S; Gococo-Benore DA; Li Z; Advani PP; Chumsri S
JAMA Oncol; 2021 Sep; 7(9):1395-1397. PubMed ID: 34292295
[TBL] [Abstract][Full Text] [Related]
9. Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care.
Garreffa E; Hamad A; O'Sullivan CC; Hazim AZ; York J; Puri S; Turnbull A; Robertson JF; Goetz MP
Eur J Cancer; 2021 Dec; 159():38-51. PubMed ID: 34731748
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Screening and Axillary Adenopathy in the Era of COVID-19 Vaccination.
Wolfson S; Kim E
Radiology; 2023 Feb; 306(2):e222040. PubMed ID: 36219117
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Vaccination and Subclinical Axillary Lymphadenopathy on Mammogram: Correspondence.
Mungmunpuntipantip R; Wiwanitkit V
Acad Radiol; 2022 Apr; 29(4):633. PubMed ID: 35058134
[No Abstract] [Full Text] [Related]
12. Post-vaccination SARS-CoV-2 axillary adenopathy. Differences with axillary metastases from breast cancer.
Armas-Conde M; Sánchez-Álvarez ÁL; Tejera-Hernández A; Vega-Benítez V; Antela-López JC; Gutiérrez-Giner MI; Hernández-Hernández JR
Cir Cir; 2022; 90(3):410-413. PubMed ID: 35636962
[TBL] [Abstract][Full Text] [Related]
13. Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients.
Özütemiz C; Krystosek LA; Church AL; Chauhan A; Ellermann JM; Domingo-Musibay E; Steinberger D
Radiology; 2021 Jul; 300(1):E296-E300. PubMed ID: 33625300
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccination and breast cancer surgery timing.
Ko G; Hota S; Cil TD
Breast Cancer Res Treat; 2021 Aug; 188(3):825-826. PubMed ID: 34156582
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Vaccination-Associated Axillary Adenopathy: Imaging Findings and Follow-Up Recommendations in 23 Women.
Mortazavi S
AJR Am J Roentgenol; 2021 Oct; 217(4):857-858. PubMed ID: 33624520
[TBL] [Abstract][Full Text] [Related]
16. Time for Resolution of COVID-19 Vaccine-Related Axillary Lymphadenopathy and Associated Factors.
Lane EG; Eisen CS; Drotman MB; Dodelzon K; Mema E; Thomas C; Prince MR
AJR Am J Roentgenol; 2022 Oct; 219(4):559-568. PubMed ID: 35583425
[No Abstract] [Full Text] [Related]
17. Response to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination: A New Diagnostic Dilemma.
Ashoor A; Shephard J; Lissidini G; Nicosia L
Korean J Radiol; 2022 Jul; 23(7):775-776. PubMed ID: 35695318
[No Abstract] [Full Text] [Related]
18. Mitigating the Impact of Coronavirus Disease (COVID-19) Vaccinations on Patients Undergoing Breast Imaging Examinations: A Pragmatic Approach.
Lehman CD; Lamb LR; D'Alessandro HA
AJR Am J Roentgenol; 2021 Sep; 217(3):584-586. PubMed ID: 33617288
[TBL] [Abstract][Full Text] [Related]
19. Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography.
Kim B; Park Y; Kim EK; Lee SH
Clin Imaging; 2021 Nov; 79():201-203. PubMed ID: 34116295
[TBL] [Abstract][Full Text] [Related]
20. Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible.
Finsterer J
Korean J Radiol; 2022 Jul; 23(7):773-774. PubMed ID: 35695321
[No Abstract] [Full Text] [Related]
[Next] [New Search]
